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Lasers could come to occupy a highly important position in the armament of medicine. They
are the brightest known sources of light, man-made or natural, and emit light having such
properties as coherence and monochromaticity. Furthermore, lasers have the ability to deliver
very brief pulses of light which can cause unique alterations in biological materials. The major
obstacle to the increased use of lasers in medicine and surgery is not the availability of laser
devices, but the dearth of basic information about laser-tissue interactions.
We have recently demonstrated that, even in turbid tissue such as the dermis, it is possible
simultaneously to induce microscopically selective thermal damage, localized to millions of
selectively absorbing targets, while sparing surrounding tissues. These "targets" may be as small
as organelles or as large as blood vessels. Such localized thermal damage is truly unique to pulsed
laser exposures. The scope and medical utility of these lesions has yet to be fully understood.
Thus, there is much research to be done in describing and characterizing laser-induced injury.
There is, however, ample evidence that several laser therapies could be improved by using
selectively absorbed, short pulses that lead to the spatial confinement of thermal injury.
Treatment of port wine stains, pigmented lesions, atheromatous arterial plaques, and the
fragmentation ofkidney and gall stones are examples. It should also be possible to use a variety of
systems to deliver exogenous laser targets on or within individual types ofcells or organelles. Such
chromophores may lead to new forms ofcancer therapy, for example.
INTRODUCTION
In the next few years, lasers will alter the practice of surgery and medicine; the
impact could be enormous. Surgical procedures will continue to become less invasive,
as it will no longer be necessary to create surgical openings large enough to
accommodate bulky instruments and hands. The access route to the surgical field can
be the size ofthe fiber optic threads used to carry the light that will then cut, seal, and
remove tissue. Other surgical procedures may be done without any cutting or
anesthesia at all. Just as the physician can see, via the endoscope, to obtain valuable
diagnostic information, the laser can send high-intensity light via the endoscope for
therapeutic purposes.
What may be some of the effects on patient care and the practice of medicine?
Operating room procedures may in part be replaced by endoscopic suite procedures.
Thus inpatient care will be replaced by outpatient procedures. The chronic GI bleeder,
for example, with a hereditary vascular lesion may be safely, less invasively, and more
effectively treated on a frequent basis, thus decreasing blood loss and removing the
need for lengthy surgical procedures with high rates of morbidity and mortality. The
judgment, approach, decisions, and referral system of physicians may be altered by
laser treatments. For example, the dysphagia of end-stage esophageal cancer can now
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be palliatively treated with either a nonrepeatable operating room procedure requiring
general anesthesia, or repeatedly and less invasively using an argon or Nd:YAG laser.
The cost ofsome laser treatments may beless than traditional treatmentsofthe past. If
chosen carefully, a single laser system costing between $20,000 and $70,000 can
potentially be used for many procedures on many patients. Lengthy, expensive,
inpatient surgical procedures may be replaced by less expensive, outpatient laser
treatments-and perhaps most important, laser treatment may improve patient care.
To date, the largest impact of lasers has been in the specialty of ophthalmology.
Retinal detachment and bleeding are now routinely treated with lasers. One of the
largest efforts in all of laser medicine research, however, is aimed at the treatment of
large-vessel pathology via catheters (e.g., laser angioplasty). Other research has shown
that the potential use of lasers in otolaryngology, gynecology, neurosurgery, cardiolo-
gy, urology, plastic surgery, dermatology, and gastroenterology far exceeds the present
applications.
To describe laser therapy in its simplest form, one could state: "Lasers can quickly
put a lot of energy into a very small volume of tissue." This energy causes a
photophysical event similar in many respects to other, well-studied, laser materials-
processing events. Thermally, lasers can cook, cut, ablate, seal, and explode the tissue.
The host response to this intervention, however, is unique because the laser energy can
be confined to a remarkably small volume (on the order of organelles) and can be
deposited in a time-frame faster than ever occurs in nature (e.g., one microsecond).
Lasers, with endoscopic delivery systems, can also be used to initiate photochemically
mediated reactions in tissues previously not available for light exposure such as vessels,
the bronchial tree, the gastrointestinal tract, thegenitourinary system, the biliary tree,
and the peritoneal and thoracic cavities.
Two scientific and technical fields have converged to increase markedly the
capabilities of laser medicine. First, laser technology has advanced, primarily in
response to the needs of the materials-processing industry, which was supported by
massive investments by the defense and communications industries. The result has
been new lasers capable of tunable wavelengths, extremely brief pulse durations, and
unmatched power. Second, fiber optic technology and endoscopy have also grown
rapidly. Development offlexible fiber optics is an advancement which has enabled the
endoscopist to see tissues directly, and thereby to target them for laser treatment of
respiratory, urinary, and gastrointestinal tracts and ofother regions.
The major obstacle to increased useoflasers in medicine and surgery is thedearth of
basic information about laser-tissue interactions. That small volume ofinformation is,
however, growing. In 1965, there weresixscientific articles published in major medical
journals about the medical applications oflasers. In 1975, therewere 24, and in theone
month of March 1985, there were 124 articles. Nevertheless, of the several hundred
kinds oflasers developed, only four or five are commonly used in medicine.
LASER PROPERTIES
The unique therapeutic capabilities of lasers are based upon the unique physical
properties inherent in laser light. The high intensity ofthe laser output is a well-known
property. Peak powers as high as 1012 watts for Q-switched and mode-locked lasers
allow a wide spectrum of phenomena to occur, from gentle heating to violent
explosions. Furthermore, because the laser is a spatially coherent source, the output
beam can be highly collimated and can befocused to a small spot size. A collimated
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TABLE I
A Partial Listing of the Lasers Currently Used in the
Clinical and Medical Research Environments
Laser (active medium) Wavelength (nm)0 Use in Medicine/Surgery
1. ArF 193 Ablationb
KrF 248 Ablationb
2. Dye Tunable Coagulation
(312-1,010) Ablationb
3. Argon 488 Coagulation
514.5 Ablationb
4. Nd:YAG 1,064.5 Disruption, coagulation
1,320 Ablation
5. CO2 10,600 Ablation
"Note that the entire spectrum from the UVC (193 nm) to the IR-C (10,600 nm) is
used.
bExperimental
beam can be precisely aimed at a specific target. Focusing allows one to couple the
light into a fiber optic, to be delivered endoscopically to many organs in the body.
The output of lasers can be extremely monochromatic. Some lasers emit light at
only one wavelength, others at several discrete wavelengths, and still others aretunable
over a broad band (refer to Table 1). Selectiveabsorption by tissuecan lead toselective
damage. For example, if a chosen wavelength is generally not well-absorbed by the
laser-exposed tissue, but is well-absorbed by isolated structures (e.g., blood vessels)
within the tissue, then millions ofthese absorbing structures can besimultaneously and
selectively heated and damaged by a single pulse of light in a process referred to as
selective photothermolysis [1]. In contrast, if a wavelength is chosen that is well-
absorbed by tissue (forexample CO2 laserlight-10.6jAm-is strongly absorbedbythe
water in tissue [2]), then the energy in the laser beam isdeposited very nearthesurface
of the irradiated tissue, and the surface layer of tissue can be quickly heated to the
point ofvaporization, leaving a well-defined crater [3,4]. This process is referred to as
photoablation.
Lasers are capable of generating light in a continuous wave (cw) or in the form of
pulses of light as short as 10 x I0-'5 seconds in duration [5]. The pulsed nature of
some lasers is the key to the spatial confinement of laser-induced heating. The laser
deposits energy in an absorbing structure, thereby rapidly heating that structure. The
structure then dissipates this heat, mainly by conduction, to adjacent tissues. The time
required for a cylindrical structure, such as a blood vessel, to cool by the process of
diffusion [6], is called the thermal relaxation time (TR) and is expressed by the
equation:
TR = r2/4a
where r is the structure's radius and a is the thermal diffusivity of tissue (approxi-
mately I0-3cm2/second) [7]. Thecooling time is important because ifthelaser pulseis
longer than the cooling time, then a significant amount of heat will diffuse out of the
target during irradiation. Although selective target damage may be possible with
somewhat longer pulses, damage to the target will be maximally confined if the laser
pulse is shorter than the target cooling time [8,9]. For example, consider oxyhemoglo-
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bin, a chromophore (i.e., an absorber of light) with absorption peaks at 415, 542, and
577 nm [10,11]. By varying the pulse duration, one can selectively heat erythrocytes
(r 3 ,um; therefore TR 20,Asec) ormicroscopic blood vessels (r 5-10 Jim, therefore
rR 60-250 Asec) or larger blood vessels plus some perivascular tissue (rR > 250
,usec).
The above-mentioned laser properties can be varied to control several basic
laser-tissue interactions. All ofthese interactions are dependent upon the absorption of
light by tissue. The laser thus deposits energy within the tissue. Often this energy takes
the form ofheat, as in photothermal ablation and selective photothermolysis; however,
if the photon energy is large enough, as it may be in the ultraviolet (UV), then it is
postulated that chemical bonds are brokenvia a non-thermal mechanism, as in ablative
photodecomposition. Photothermolysis and photoablation, both thermal and non-
thermal, are further discussed below. Another laser-tissue interaction called photodis-
ruption can cause damage by photon-induced acoustic shock waves. These shock waves
result from very tight focusing of laser light. Such focusing is only possible in
nonscattering media such as the eye. Because photodisruption therapy is likely to be of
import only in the field ofophthalmology, there will be little further discussion ofthat
laser-tissue interaction in this paper.
PHOTOABLATION
Ablation refers to the removal of surface material. Photoablation is not a new
phenomenon; it has been used in both industry [12,13] and medicine [14,15] for a long
time. The mechanisms of photoablation are either entirely thermally based (as
exemplified by the CO2 laser) or based upon a process called photodecomposition (as
exemplified by ultraviolet-emitting excimer lasers).
Photothermal ablation is initiated by absorption oflaser light near thetissuesurface;
as surface temperaturerises, a phasechangeoccurs, and the tissue isvaporized, leaving
a crater in the tissue surface. The depth of this crater and the amount of thermally
denaturated tissue left behind depend upon laser wavelength, exposure parameters,
and material properties. The major surgical advantage over cold-knife dissection is
thatofcontrolled hemostasis [14,16]; a small amount ofheat remains at theedgeofthe
ablation site to enhance blood coagulation and microvessel sealing. Advantages over
electrocautery techniques are that, with a laser, one can have better control of tissue
heating, depth of ablation or incision, and the amount of residual tissue thermal
damage [17].
Ablative photodecomposition was discovered during the etching ofpolymer films by
high-intensity ultraviolet laser light [18]. Ultraviolet light is now being used experi-
mentally to cut biologic materials [19,20]. Photodecomposition is initiated by the
absorption of focused UV laser radiation. It is postulated that UV photons have
sufficient energy (e.g., 6.4 eV photon at 193 nm) to break bonds in a hydrocarbon
chain, so that smaller, fragmented molecules are produced. The fragments rapidly fly
off, leaving a shallow crater (typically <1 Am deep) in the material surface. In some
cases, there is no detectable thermal damage to the material adjacent to the ablation
crater [21]. Recent 248 nm studies in human andguinea pig skin, however, have shown
some thermal damage to collagen and cellular structures within 100 to 200 ,um of the
ablative edge. Thus, for some biologic materials, a photothermal mechanism may be at
least partially responsible for the ablation [20]. The proportion of thermal versus
decomposition mechanisms in UV ablation is at this time uncertain [22].
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The depth of the etch mark is controlled by the mechanical properties of the tissue
and the laser wavelength, radiant exposure, irradiance, pulse repetition rate, spot size,
pulse duration, and, for continuous wave lasers, dwell time. Generally, a small increase
in radiant exposure means that more tissue receives an ablative dose of laser energy;
thus the depth of the crater increases [20,21,23]. Similarly, somewhat more tissue is
ablated during slightly longer pulses of equivalent irradiance [24]. Wavelength
controls the depth oflight penetration into the tissue and the site ofabsorption. A very
short penetration depth (e.g., at 193 nm, the penetration depth is approximately 2.0
,im) means the light is absorbed very strongly; thus little tissue (e.g., 2.0 ,um) is
removed with every pulse oflight. A slightly longer penetration depth (e.g., at 248 nm
the penetration depth in dermis is 50-100 im) means more tissue can be ablated per
pulse. Note, however, that at a near infinite penetration depth so little light energy is
absorbed that ablation is not possible.
The zone ofthermal damage at the edge ofthe ablation crater is also controlled by
the laser exposure parameters. The shorter the penetration depth, the more focal the
deposition oflaser energy; the more localized the confinement ofheat, the smaller the
zone of thermal damage [24]. Thus, the pulse duration of the laser also controls the
zone of thermally altered tissue. When the tissue surface is heated, thermal diffusion
controls the heating of the tissue surrounding the irradiated surface volume. If the
surface volume is heated faster than it can cool (i.e., ifthe pulse duration is much less
than the thermal relaxation time of the heated volume), the surrounding tissue is
minimally heated. Furthermore, when the surface material flies off, a significant
percentage of energy leaves, and little energy is left to heat the remaining tissue
[19,20,211. Laser intensity is also important. Laser pulses that lack sufficient intensity
to ablate tissue simply heat the surface of the tissue and can cause thermal damage to
underlying structures [25]. To minimize the zone ofthermally altered tissue surround-
ing the ablation crater, short pulses of strongly absorbed, high-intensity light are
needed. Depending upon the application, one may not want any zone of thermal
damage (for example, in corneal surgery) or may want only a small zone for sealing
vessels and limiting bleeding in the area adjacent to the crater (e.g., in the skin).
Although the amount ofmaterial removed per pulse is quite small, a "deep" cut can
be achieved by using many pulses. The zone of thermal damage surrounding the cut
can be as minimal as for one pulse. Also, although the mutagenic and carcinogenic
capabilities ofultraviolet radiation are well known, most ofthe tissue irradiated by the
UV light is ablated; little tissue receiving a sub-ablative dose is left intact. In addition,
recent studies, while confirming the cytotoxic and mutagenic potential of248 nm laser
radiation, have shown that 193 nm radiation was cytotoxic but not very mutagenic
when compared with controls. At 193 nm, the nucleus, and therefore the DNA,
appears to be effectively shielded by strongly absorbing perinuclear components [26].
The UV laser ablation of corneal tissue [19] may help perfect the correction of
myopia by radial keratomy [27,28]. The advantageofusing the UV laser asopposed to
a diamond knife are that the laser may offer better control over the depth and
positioning of the cuts, and there is perhaps less chance of an adverse host response
because there is very little damage to the tissue adjacent to the cut [29].
Lasers used in an ablation mode may also provide an effective means of removing
atherosclerotic plaque. The ultimategoal isquite clear: the removal ofplaque in such a
manner that normal vessel structure is unaltered and the atherosclerotic lesion does not
reform [30]. It has been shown that fibrous plaque absorbs twice as strongly between
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420 and 530 nm as normal aortic wall. Carotenoids, known components ofplaque, also
absorb strongly in this region. Thus, oral administration of carotenoids may further
enhance the selective absorption ofplaque, providing a spectral region in which plaque
can be selectively ablated [31].
PHOTOTHERMOLYSIS
Photothermolysis refers to the light-induced heating ofselectively absorbing targets
[1]. The basic elements for achieving this are: (1) selective absorption of the incident
light by the pigmented "target" structures within otherwise relatively nonabsorbing
tissue, and (2) confinement of the resultant heat generated within these target
structures. Irreversible denaturation of the targets then becomes possible. Thus,
photothermolysis is dependent upon a light source that: (a) is intense, so that rapid
heating can be achieved; (b) emits light at a wavelength that is well-absorbed by the
selected target but relatively poorly absorbed by the surrounding tissue; and (c) is
pulsed, or rapidly scanned, so that heat can be generated in the targets before much
thermal diffusion to surrounding tissues can occur.
For example, dermal microvessels can be selectively damaged by irradiation with a
wavelength that passes well through the overlying epidermis and is then strongly
absorbed by blood in the underlying dermal vessels. The chief visible chromophores
(pigments) in blood are hemoglobins and bilirubin; in the epidermis, melanin is the
majorchromophore (see Fig. 1). Oxyhemoglobin hasabsorption peaks at 418, 540, and
577 nm. Melanin absorption and dermal scattering at 418 nm [32] are quite strong,
but decrease at longer wavelengths. The sequelae of melanin absorption is damage to
melanin-containing epidermal cells, which is undesirable for the goal of selective
vascular injury. The longer wavelength 577 nm light is less strongly absorbed by
melanin and less strongly scattered within the dermis, however, and therefore
represents a wavelength at which dermal vessels can be selectively damaged without
significant epidermal injury in Caucasians [1].
To maximally confine the deposited energy within the targeted structure (the
microvessels), one must choose an exposure duration less than or about equal to the
target thermal relaxation time, TR. Table 2 gives approximatethermal relaxation times
for biologic structures ofvarious sizes. The ectatic cutaneousvessels found in port wine
stains (PWS) [33] are typically about 35 ,tm in diameter. In PWS patients, these
abnormal superficial vessels cause the red to violet color ofthese "birthmarks" and can
be markedly disfiguring. A pulse duration of less than 1 msec confines selectively
absorbed laser energy within these vessels and, hence, a 577 nm laser exposure of 1
msec or less may be ideal for selective treatment of PWS lesions. On the other hand,
pulse durations less than about 10 ,usec should confine the thermal energy to the
erythrocytes, the cells in which all oxyhemoglobin normally occurs. For these short
pulse durations, violent erythrocyte rupture and resultant mechanical vessel wall
damage appears to occur. Exposure or pulse durations of longer than about 20 ,usec
therefore may be preferable to avoid hemorrhage, yet still damage the abnormal
vessels of PWS lesions.
Experimental verification of the above theoretical predictions was obtained in a
series of studies. By irradiating normal human forearm skin with 300 nsec (0.3 ,4sec)
pulse duration, 577 nm wavelength light from a dye laser [34], the light-microscopic
histologic alterations in Caucasian skin were limited to vascular structures, particu-
larly the superficial venous plexus (SVP). At 590 nm, a wavelength only 13 nm away
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FIG. 1. The absorption spectra ofhemoglobin, oxyhemoglobin, melanin, and bilirubin; solvent indicated in
parentheses. Note that for wavelengths greater than 700 nm, the scale change for DOPA-melanin is x 10,
while for Hb and HbO2 it is x 100. Selective photothermolysis of cutaneous blood vessels is possible at a
wavelength that is relatively well-absorbed by blood constituents (e.g., HbO2) but is poorly absorbed by
structures that intervene between the light source and the vessels (e.g., melanin).
from 577 nm but much less strongly absorbed by blood, no vascular changes were
observed, confirming the primary role of oxyhemoglobin absorption. Using an in vivo
hamster cheek pouch model, vessels could be directly observed during 577 nm, 300
nsec irradiation [1]. As the radiant exposure dose is increased, hemoglobin denatura-
tion and protein coagulation, then hemostasis, and finally vessel rupture occur. As
discussed above, the short pulse duration appears to cause violent erythrocyte rupture
and vessel wall damage. A subsequent study in humans comparing 1.5, 10, 56, 200, and
360 ,usec, 577 nm pulses [35] supports the role of pulse duration in controlling vessel
rupture, as expected. Histologic evidence indicates that pulses shorter than 20 ,tsec
cause erythrocyte and vessel wall rupture with subsequent hemorrhage into the
surrounding dermis. The longer pulses heat the entire vessel, causing coagulation and
irreversible but selective vascular damage without apparent vessel rupture.
Selective photothermolysis is based upon achieving a damaging temperature in
target structures via a photon-induced temperature rise. Thus, more laser energy
should be needed to reach this damaging temperature if the ambient tissue tempera-
TABLE 2
The Thermal Relaxation Time of Various-Sized Structures
Radius (,lm) TR Structure
1 2.5,usec Mitochondrian
3 23 Asec Red blood cell
7 120,sec Capillary
10 250 usec Arteriole
15 560,Msec Venule
35 3 msec Ectatic vessel
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ture is lowered. Indeed, at a skin temperature of 200C, a larger radiant exposure (1.50
J/cm2) was needed to induce purpura than at 330C (1.29 J/cm2) [36].
The above research is the basis for an improved laser treatment of port wine stains
(PWS), a congenital abnormal collection of ectatic dermal vessels. Port wine stains
have been treated with several lasers; namely, the ruby [37], CO2 [38], and argon [39].
Treatment with each of these lasers can lead, however, to unacceptable scarring
because ofgeneralized epidermal and dermal damage. Using a dye laser emitting a 577
nm one-millisecond or shorter pulse of light, improved cosmetic results might be
expected, as previously discussed [40]. Initial studies with 1 ,sec pulses were poor,
probably because of the hemorrhage induced by these short pulses [41]. Compared
with conventional argon or CO2 laser therapy, however, very encouraging results have
been seen in PWS patients treated with 360 Asec pulses [42]. No scarring was noted,
and clearance of the irradiated area was observed in six weeks without the epidermal
damage or wound care required with other lasers.
When vessel destruction is desired, hemoglobin is not always on appropriate target
chromophore because other overlying chromophores may compete too strongly for
absorption. For example, in the retina, absorption by melanin in the retinal pigment
epithelium (RPE) and macular pigments limits the potential of selectively targeting
the neovascularization that occurs in senile macular degeneration [43]. Laser treat-
ment with, for example, a krypton laser (red line at 647 nm) [43,44] appears to limit
choroidal neovascularization, but also produces a permanent scotoma by destruction of
the overlying RPE and neural retina. Light at 577 nm is also too strongly absorbed by
the RPE to avoid scotomas, and, at present, foveal lesions invariably lead to central
blindness. A potential solution is to inject an exogenous chromophore into the blood,
i.e., a stable non-toxic dye, that has a strong absorption where the RPE and macular
pigments have weak absorption. Such a spectral region exists in the near-infrared.
The potential feasibility of using this near-infrared exogenous chromophore
approach was demonstrated in vivo in albino rabbit eyes [45], using a 694 nm pulsed
ruby laser, and indocyanine green as the exogenous chromophore. Indocyanine green,
currently used clinically for the indicator dilution method determination of cardiac
output, has a broad absorption peak near 805 nm and binds together to albumin, thus
remaining intravascular. The ruby laser light is strongly absorbed in the short-
wavelength tail ofthedye's absorption band. Other, near infrared lasers-for example,
the erbium laser- are probably better suited to optimize this potential new treatment
modality for possible use in patients.
Another example of selective photothermolysis is the selected targeting of melano-
somes with laser pulses less than 1 ,usec in duration, at wavelengths selectively
absorbed by melanin. Skin of normal human volunteers was exposed to 20 nsec pulses
from a xenon fluoride (XeF) excimer laser (351 nm wavelength) [25]. For radiant
exposures greater than 0.12 J/cm2, there was disruption of the melanosomes within
melanocytes and basal keratinocytes by electron microscopy. Biopsies at 24 hours
showed subsequent degeneration of these melanin-containing cells. Langerhans cells,
and other nonmelanin-containing epidermal cells were unaltered. Thus, selective
thermolysis ofpigmented organelles and single cells within tissue is possible.
Thus far, several exogenous chromophore systems have been discussed (carotenoids,
indocyanine green) for thermally mediated selective photothermolysis or ablation.
Photochemically mediated damage, however, offers a greater range of possible
exogenously targetted phototoxic effects. One such scheme involves delivering photo-
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toxic chromophore to the site ofinterestvia linkage to monoclonal antibodies (MAb's).
Hematoporphyrin (HP) diahydiazide has been linked to the oxidized carbohydrate
moiety on the Fc region ofanti-T cell MAb's. MAb binding specificity and HP singlet
oxygen production were unaffected, with conjugation ratios between 0.85 and 3.0
HP/MAb. The killing ofboth leukemia and stimulated T cells was both light dose and
HP concentration dependent [47,48] and specific to the cells targeted by the MAb.
The mechanism of cell killing in these studies probably involves singlet oxygen
production.
CONCLUSIONS
A few ofthe basic mechanisms oflaser-tissue interactions have been presented. The
number ofpotential therapies is large; however, laser medicine is still in its infancy. Of
the hundreds of lasers now available, only a few are used for therapy, mainly because
our understanding of basic laser-tissue interactions is limited. Elucidation of these
interactions is difficult, requiring expertise from a wide variety ofdisciplines including
engineering, physics, chemistry, immunology, and an array of medical specialties.
Sophisticated lasers and other technology are also required. The biologic effects of
many laser-tissue interactions are poorly understood but certainly open to careful
study. Already the benefits of such collaborative research are being seen. Port wine
stains and pigmented skin lesions may be better treated using selective photothermoly-
sis, as discussed. We now have femtosecond (10"5 seconds) ranging techniques for
accurate in vivo diagnosis ofocular pathology [49], and doppler shift measurements of
capillary blood flow [50]. Recently, in vivo fragmentation/ablation of urinary calculi
(calcium oxalate stones) was demonstrated, using a dye laser tuned to 450 nm with a
one-microsecond pulse duration [51]. Other research will enhance in vivo spectroscopy
and potentially lead to the development of "smart lasers," in which the laser
parameters (e.g., pulse duration) are controlled by a fast diagnostic feedback system.
The financial cost of laser research may be initially high; however, the potential to
improve patient care is immense; the prospect ofchanging expensive, high-morbidity,
invasive, inpatient surgical operations into less expensive, low morbidity, non-invasive,
outpatient procedures is in the best interest ofpatient and physician alike.
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